Long COVID Treatment Breakthrough: From Symptoms to Science-Backed Solutions Previous articles: Hidden Danger: Why MIS-A Strikes Adults Months After COVID-19 Recovery Solving Long COVID Symptoms: New Research Reveals Hidden Immune Patterns Autoimmunity and COVID Vaccines: Risk of
Infectious Disease
Treatment for Latent TB: Critical Steps Internists Often Miss
Treatment for Latent TB: Critical Steps Internists Often Miss Check out our extensive video library (see channel for our latest videos) Introduction Latent tuberculosis infection remains a significant public health concern in the United States. Estimates suggest that up to 13 million individuals are
Managing HIV in Primary Care: What Every Physician Needs to Know in 2025
The Spectrum of AI Influence- Comparative Impact Across Medical Specialties
H Pylori New Treatment Breakthrough: When Antibiotics Stop Working
H Pylori New Treatment Breakthrough: When Antibiotics Stop Working Introduction Helicobacter pylori (H. pylori) infection remains one of the most widespread and clinically significant bacterial infections worldwide. By 2015, an estimated 4.4 billion individuals were infected, with the highest prevalence observed in developing countries
Neurocysticercosis: The Hidden Brain Parasite Crossing Global Borders in 2025
Neurocysticercosis: The Hidden Brain Parasite Crossing Global Borders in 2025 Introduction Neurocysticercosis remains the most prevalent parasitic infection of the human central nervous system (CNS) and continues to represent a major global health challenge. Current estimates suggest that more than 50 million individuals
Solving Long COVID Symptoms: New Research Reveals Hidden Immune Patterns
Solving Long COVID Symptoms: New Research Reveals Hidden Immune Patterns Introduction More than half of individuals with laboratory-confirmed SARS-CoV-2 infection report at least one persistent symptom, underscoring the urgent need for evidence-based approaches to address Long COVID. The condition is highly complex and heterogeneous.
